RxDoctor Payments DataLook up a doctor →

Viviane Bunin, MD

Rheumatology · Bellevue, WANPI 1841498003

Payments from drug & device makers

$38,478in general payments, 2019–2025

Across 581 payments — averaging $66.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$12K
  • UCB, Inc.$11K
  • AstraZeneca$3K
  • Johnson & Johnson$3K
  • Sobi, Inc$2K
  • Lilly USA, LLC$2K
  • plus $6K from 18 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$38,478 in reported general payments places this provider in the 85th percentile of 157 rheumatology providers in Washington.

See all rheumatology providers in Washington

Medicare billing

Part B allowed, 2024
$661,837
Medicare patients
59
Services billed
23,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Bellevue

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →